Patents by Inventor Günther Gerhard Jung

Günther Gerhard Jung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antigen specific activated T-lymphocytes, detection and use
    Publication number: 20060171954
    Abstract: The invention concerns autoreactive peptides, peptide-MHC complexes, T cell subpopulations that react thereto as well as diagnostic and therapeutic applications of these compounds.
    Type: Application
    Filed: April 5, 2006
    Publication date: August 3, 2006
    Applicant: Roche Diagnostics GmbH
    Inventors: Josef Endl, Peter Stahl, Winfried Albert, Guenther-Gerhard Jung, Dolores Schendel, Edgar Meinl, Klaus Dornmair
  • Antigen-specific, activated T lymphocytes, detection and use
    Patent number: 7064190
    Abstract: The invention concerns autoreactive peptides, peptide-MHC complexes, T cell subpopulations that react thereto as well as diagnostic and therapeutic applications of these compounds.
    Type: Grant
    Filed: November 16, 1999
    Date of Patent: June 20, 2006
    Assignee: Roche Diagnostics GmbH
    Inventors: Josef Endl, Peter Stahl, Winfried Albert, Guenther-Gerhard Jung, Dolores J. Schendel, Edgar Meinl, Klaus Dornmair
  • HCV peptide antigens and methods for the determination of HCV
    Patent number: 6592871
    Abstract: Novel HCV peptide antigens are described representing partial sequences of the C-100-3 and env/core with C-regions. These peptide antigens are suitable for the determination of HCV antibodies as immunogens for the production of antibodies against HCV and as vaccines for the production of vaccines against HCV.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: July 15, 2003
    Assignee: Roche Diagnostics GmbH
    Inventors: Christoph Seidel, Gertraud Ehrlich-Weinreich, Hubert Bayer, Ursula Henrike Wienhues, Günther Gerhard Jung, Hans Georg Ihlenfeldt
  • Method for serological typing using type-specific antigens
    Patent number: 6447992
    Abstract: The invention concerns a method for typing antibodies in a sample liquid by means of type-specific antigens and in particular a method for typing antibodies to the hepatitis C virus and peptide antigens suitable for this.
    Type: Grant
    Filed: July 12, 1999
    Date of Patent: September 10, 2002
    Assignee: Roche Diagnostics Gmbh
    Inventors: Cristoph Seidel, Ursula-Henrike Wienhues-Thelen, Urban Schmitt, Günther-Gerhard Jung, Hans-Georg Ihlenfeldt, Wolfgang Kraas
  • HCV peptide antigens and methods for the determination of HCV
    Patent number: 6183949
    Abstract: Novel HCV peptide antigens are described representing partial sequences of the C-100-3 and env/core with C-regions. These peptide antigens are suitable for the determination of HCV antibodies as immunogens for the production of antibodies against HCV and as vaccines for the production of vaccines against HCV.
    Type: Grant
    Filed: February 21, 1996
    Date of Patent: February 6, 2001
    Assignee: Roche Diagnostics GmbH
    Inventors: Christoph Seidel, Gertraud Ehrlich-Weinreich, Hubert Bayer, Ursula H Wienhues, Günther Gerhard Jung, Hans Georg Ihlenfeldt
  • HCV peptide antigens and method of determining HCV
    Patent number: 5674676
    Abstract: New HCV peptide antigens are described. These peptide antigens are suitable for the determination of HCV antibodies as immunogens for the preparation of antibodies to HCV and as immunogens for the preparation of vaccines to HCV.
    Type: Grant
    Filed: August 6, 1993
    Date of Patent: October 7, 1997
    Assignee: Boehringer Mannheim GmbH
    Inventors: Christoph Seidel, Ursula-Henrike Wienhues, Hubert Bayer, Guenther-Gerhard Jung, Hans Georg Ihlenfeldt